Skip to main content
Signal8
LAPPE RODNEY W profile photo

Rodney W. Lappe

CIK: 0001579826

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Design Therapeutics, Inc. logo
DSGN

Design Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Design Therapeutics, Inc. logo
    DSGN

    Design Therapeutics, Inc.

    Jun 9, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    30K shares-
  • Design Therapeutics, Inc. logo
    DSGN

    Design Therapeutics, Inc.

    Jun 10, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    19K shares-
  • Design Therapeutics, Inc. logo
    DSGN

    Design Therapeutics, Inc.

    Jan 2, 2025
    Award(A)

    Stock option (right to buy)

    Direct
    26K shares-

1-3 of 3

About LAPPE RODNEY W

LAPPE RODNEY W (SEC CIK 0001579826) files insider reports with the SEC as Director of Design Therapeutics, Inc. (DSGN).

Signal8 holds 3 ownership filings by LAPPE RODNEY W, all Form 4s, filed between Jan 6, 2025 and Jun 11, 2026. Those filings report 3 transactions, from Jan 2, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on LAPPE RODNEY W's filings is in CARLSBAD, CA.

Recent filings by LAPPE RODNEY W

  • Jun 9, 2026: Grant or award of DSGN derivative securities (Form 4, code A).
  • Jun 10, 2025: Grant or award of DSGN derivative securities (Form 4, code A).
  • Jan 2, 2025: Grant or award of DSGN derivative securities (Form 4, code A).

Other insiders filing for Design Therapeutics, Inc. (DSGN)

How to read Form 4 transaction codes